Related Experiment Video
Updated: Jun 8, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
False bisalbuminemia and hyperalphafetoproteinemia
A Boujelbene1, I Hellara, F Neffati
1Laboratoire de biochimie et de toxicologie, hôpital universitaire de Monastir, 5000 Monastir, Tunisia.
Capillary electrophoresis can show interfering peaks, mimicking conditions like bisalbuminemia. In a patient with pancreatic cancer, an albumin shoulder was caused by alphafetoprotein interference, not true bisalbuminemia.
Area of Science:
- Clinical chemistry
- Electrophoresis techniques
- Protein analysis
Background:
- Capillary electrophoresis (CE) offers high resolution for serum protein analysis.
- Interferences in CE can manifest as aberrant peaks or shoulders, potentially leading to misdiagnosis.
- Accurate interpretation of electrophoretic patterns is crucial for patient management.
Observation:
- A 68-year-old patient with pancreatic cancer presented with a shoulder in the albumin region during serum protein electrophoresis.
- This finding on the Capillarys (Sebia) system initially suggested bisalbuminemia.
- The patient's clinical presentation and other diagnostic tests were considered.
Findings:
- The observed albumin shoulder was definitively identified as an interference.
- Alphafetoprotein was confirmed as the interfering substance responsible for the artifactual peak.
- This interference mimicked the electrophoretic pattern of bisalbuminemia.
Implications:
- This case highlights the importance of recognizing and differentiating CE interferences from actual biological variations.
- Understanding potential interferences, such as alphafetoprotein, is critical for accurate diagnosis in protein electrophoresis.
- Proper identification of artifacts ensures correct patient diagnosis and treatment, especially in complex cases like cancer.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Drug Distribution: Plasma Protein Binding
Diabetic Nephropathy
Jaundice
Inborn Errors of Metabolism
